Evidence map›Paper›PMID 26646931›Full record

ArticleCirculation research2016

Association of MicroRNAs and YRNAs With Platelet Function.

Dorothee Kaudewitz, Philipp Skroblin, Lukas H Bender, Temo Barwari, Peter Willeit, Raimund Pechlaner, Nicholas P Sunderland, Karin Willeit, Allison C Morton, Paul C Armstrong and 14 more

Open access · greenAbstract read
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 202 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. miR-146a mimic therapy protects against platelet-mediated thrombosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Influence of Genetic and Epigenetic Factors of P2YCardiovascular drugs and therapy · 2024
    Review
  11. MicroRNAs and Cardiovascular Disease Risk.Current cardiology reports · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Immunomodulatory role of glycoRNAs in the brain.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 2 countries.

Dorothee Kaudewitz *King's British Heart Foundation Centre, King's College London, UK.
Philipp Skroblin *King's British Heart Foundation Centre, King's College London, UK.
Lukas H BenderKing's British Heart Foundation Centre, King's College London, UK.
Temo BarwariKing's British Heart Foundation Centre, King's College London, UK.
Peter WilleitDepartment of Public Health and Primary Care, University of Cambridge, UK.
Raimund PechlanerDepartment of Neurology, Medical University Innsbruck, Austria.
Nicholas P SunderlandKing's British Heart Foundation Centre, King's College London, UK.
Karin WilleitDepartment of Neurology, Medical University Innsbruck, Austria.
Allison C MortonSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Paul C ArmstrongWilliam Harvey Research Institute, Queen Mary University of London, UK.
Melissa V ChanWilliam Harvey Research Institute, Queen Mary University of London, UK.
Ruifang LuKing's British Heart Foundation Centre, King's College London, UK.
Xiaoke YinKing's British Heart Foundation Centre, King's College London, UK.
Filipe GracioBiomedical Research Centre, King's College London, UK.
Katarzyna DudekKing's British Heart Foundation Centre, King's College London, UK.
Sarah R LangleyKing's British Heart Foundation Centre, King's College London, UK.
Anna ZampetakiKing's British Heart Foundation Centre, King's College London, UK.
Emanuele de RinaldisBiomedical Research Centre, King's College London, UK.
Shu YeDepartment of Cardiovascular Sciences, University of Leicester, UK.
Timothy D WarnerWilliam Harvey Research Institute, Queen Mary University of London, UK.
Alka SaxenaBiomedical Research Centre, King's College London, UK.
Stefan KiechlDepartment of Neurology, Medical University Innsbruck, Austria.
Robert F StoreyDepartment of Cardiovascular Science, University of Sheffield, UK.
Manuel MayrKing's British Heart Foundation Centre, King's College London, UK.
University of Cambridge · GBInnsbruck Medical University · ATQueen Mary University of London · GBUniversity of Sheffield · GBWilliam Harvey Research Institute · GBSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

Austrian Science Fund FWF J 3679British Heart Foundation FS/13/18/30207British Heart Foundation FS/13/2/29892British Heart Foundation SP/12/5/29574Diabetes UK 12/0004530
6 · The paper itself

Abstract

rationalePlatelets shed microRNAs (miRNAs). Plasma miRNAs change on platelet inhibition. It is unclear whether plasma miRNA levels correlate with platelet function.

objectiveTo link small RNAs to platelet reactivity. METHODS AND

resultsNext-generation sequencing of small RNAs in plasma revealed 2 peaks at 22 to 23 and 32 to 33 nucleotides corresponding to miRNAs and YRNAs, respectively. Among YRNAs, predominantly, fragments of RNY4 and RNY5 were detected. Plasma miRNAs and YRNAs were measured in 125 patients with a history of acute coronary syndrome who had undergone detailed assessment of platelet function 30 days after the acute event. Using quantitative real-time polymerase chain reactions, 92 miRNAs were assessed in patients with acute coronary syndrome on different antiplatelet therapies. Key platelet-related miRNAs and YRNAs were correlated with platelet function tests. MiR-223 (rp=0.28; n=121; P=0.002), miR-126 (rp=0.22; n=121; P=0.016), and other abundant platelet miRNAs and YRNAs showed significant positive correlations with the vasodilator-stimulated phosphoprotein phosphorylation assay. YRNAs, miR-126, and miR-223 were also among the small RNAs showing the greatest dependency on platelets and strongly correlated with plasma levels of P-selectin, platelet factor 4, and platelet basic protein in the population-based Bruneck study (n=669). A single-nucleotide polymorphism that facilitates processing of pri-miR-126 to mature miR-126 accounted for a rise in circulating platelet activation markers. Inhibition of miR-126 in mice reduced platelet aggregation. MiR-126 directly and indirectly affects ADAM9 and P2Y12 receptor expression.

conclusionsLevels of platelet-related plasma miRNAs and YRNAs correlate with platelet function tests in patients with acute coronary syndrome and platelet activation markers in the general population. Alterations in miR-126 affect platelet reactivity.

Indexed as

Platelet ActivationAcute Coronary SyndromeAnimalsBlood PlateletsCell Line, TumorGene Expression ProfilingHumansMaleMiceMice, Inbred C57BLMicroRNAsOligonucleotidesPlatelet Aggregation InhibitorsPlatelet Function TestsPolymorphism, Single NucleotideReal-Time Polymerase Chain ReactionMicroRNAsMIRN126 microRNA, humanMIRN126 microRNA, mouseOligonucleotidesPlatelet Aggregation Inhibitorsacute coronary syndromebiomarkersblood plateletmicro-RNAspolymorphism, single nucleotide

Identifiers

PMID26646931
PMCPMC5065093
OpenAlexW2193219814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.